Hotline:
+ 49 (0) 2204 2918806
Manufacturer: GlobalData

Global In Vitro Diagnostics Market Analysis and Forecasts to 2015

NULL
SKU:GDME0095IAR / 65296
Language version:English
Report Type:Marktstudie
Nr of pages:467 pages
Edition:0
Rating:Für diese Studie liegt keine Bewertung vor.
$4,000.00   *
* Click here to switch the currency you want to pay in.
Screenshots
Global In Vitro Diagnostics Market Analysis and Forecasts to 2015
More about this report
Table of Contents
Other relevant reports
Our guarantee
 

Content of the report

Introduction

GlobalData’s “Global In Vitro Diagnostics (IVD) Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the global IVD market. The report provides market landscape, competitive landscape and market trends information on seven market categories including clinical chemistry, genetic testing, histology and cytology, immunochemistry, infectious immunology, microbiology culture and haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

- Forecasts & Analysis of the global IVD market to 2015.
- Geographical coverage across 12 major countries which include the US (United States), the UK (United Kingdom), France, Italy, Spain, Canada, Germany, Japan, India, China, Australia and Brazil
- Market segmentation by clinical chemistry, genetic testing, histology and cytology, immunochemistry, infectious immunology, microbiology culture and haematology.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of the leading companies and competitive landscape including 2008 company market share analysis. Key companies covered include F. Hoffmann-La Roche Ltd, Siemens Medical Solutions, Abbott Laboratories, Beckman Coulter, Inc., Biomerieux Sa and Ortho-Clinical Diagnostics Inc.
- Analysis of key IVD pipeline products, new technologies and clinical trials.
- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Highlights

Reasons to buy

- Understand what the new growth opportunities are within the global IVD market.
- Develop a clear knowledge & understanding of the global IVD competitor landscape and how this will change to 2015.
- Identify acquisition opportunities across the global IVD market.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Make more informed business decisions from the insightful and in-depth analysis of the market and the factors shaping it.

Report Highlights
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
bioMerieux S.A.